---
title: Domperidone + Omeprazole + Simethicone
description: >-
  This combination medication is prescribed for gastrointestinal disorders like
  gastroesophageal reflux disease (GERD), dyspepsia, peptic ulcers, and other
  conditions involving excessive gas, bloating, and discomfort. It is also used
  to manage functional dyspepsia and flatulence.
is_banned: false
lastModified: '2025-09-22T17:22:09.114Z'
faqs:
  - q: >-
      What is the recommended dosage for Domperidone + Omeprazole +
      Simethicone?**


      **A:**  Typical adult dosage is omeprazole 20 mg + domperidone 10 mg twice
      daily before meals, with simethicone 20-40 mg after meals and at bedtime.
    a: >-
      A:**  Typical adult dosage is omeprazole 20 mg + domperidone 10 mg twice
      daily before meals, with simethicone 20-40 mg after meals and at bedtime.
  - q: >-
      Can this combination be used in children?**


      **A:**  Safety and efficacy haven't been fully established in children
      under 12. Simethicone can be used based on weight, but omeprazole and
      domperidone dosing needs careful consideration in pediatrics.
    a: >-
      A:**  Safety and efficacy haven't been fully established in children under
      12. Simethicone can be used based on weight, but omeprazole and
      domperidone dosing needs careful consideration in pediatrics.
  - q: >-
      What are the common side effects?**


      **A:**  Headache, diarrhea, abdominal pain, flatulence, dry mouth,
      drowsiness, dizziness.
    a: >-
      A:**  Headache, diarrhea, abdominal pain, flatulence, dry mouth,
      drowsiness, dizziness.
  - q: >-
      Are there any serious side effects?**


      **A:** Yes, though rare.  Cardiac arrhythmias, extrapyramidal reactions,
      gynecomastia, and hypersensitivity reactions are possible.
    a: >-
      A:** Yes, though rare.  Cardiac arrhythmias, extrapyramidal reactions,
      gynecomastia, and hypersensitivity reactions are possible.
  - q: >-
      What are the contraindications?**


      **A:** Hypersensitivity, GI bleeding/obstruction, prolactinoma, severe
      hepatic impairment, and concomitant use of QT-prolonging drugs.
    a: >-
      A:** Hypersensitivity, GI bleeding/obstruction, prolactinoma, severe
      hepatic impairment, and concomitant use of QT-prolonging drugs.
  - q: >-
      What are the key drug interactions?**


      **A:**  Numerous drug interactions exist, primarily through CYP450
      enzymes.  Interactions with azoles, macrolides, and QT prolonging drugs
      are especially important.
    a: >-
      A:**  Numerous drug interactions exist, primarily through CYP450 enzymes. 
      Interactions with azoles, macrolides, and QT prolonging drugs are
      especially important.
  - q: >-
      Can this be used during pregnancy and breastfeeding?**


      **A:**  Use cautiously during pregnancy only if the benefit clearly
      outweighs the risk. Breastfeeding is not generally recommended due to the
      presence of domperidone in breast milk.
    a: >-
      A:**  Use cautiously during pregnancy only if the benefit clearly
      outweighs the risk. Breastfeeding is not generally recommended due to the
      presence of domperidone in breast milk.
  - q: >-
      What should I monitor in patients taking this combination long-term?**


      **A:** Electrolytes (magnesium, calcium), cardiac rhythm, and any signs of
      extrapyramidal symptoms, especially in elderly patients.
    a: >-
      A:** Electrolytes (magnesium, calcium), cardiac rhythm, and any signs of
      extrapyramidal symptoms, especially in elderly patients.
  - q: >-
      Should I advise any lifestyle modifications?**


      **A:** Patients should avoid alcohol and fatty meals, which can exacerbate
      symptoms or reduce drug efficacy.
    a: >-
      A:** Patients should avoid alcohol and fatty meals, which can exacerbate
      symptoms or reduce drug efficacy.
  - q: >-
      Is there a risk of long-term PPI use?**


      **A:** Yes, there's a potential increased risk of osteoporosis and bone
      fractures, especially with high doses and prolonged use.
    a: >-
      A:** Yes, there's a potential increased risk of osteoporosis and bone
      fractures, especially with high doses and prolonged use.
---
## **Usage**

This combination medication is prescribed for gastrointestinal disorders like gastroesophageal reflux disease (GERD), dyspepsia, peptic ulcers, and other conditions involving excessive gas, bloating, and discomfort. It is also used to manage functional dyspepsia and flatulence.

**Pharmacological Classification:** Gastrointestinal agent (combination of a proton pump inhibitor, prokinetic, and antiflatulent)

**Mechanism of Action:** This combination works through the synergistic action of its components:

*   **Omeprazole:** Reduces stomach acid production by inhibiting the H+/K+-ATPase enzyme system in gastric parietal cells.
*   **Domperidone:**  Improves gastric motility and emptying by blocking dopamine receptors in the chemoreceptor trigger zone. It does not readily cross the blood-brain barrier, minimizing extrapyramidal side effects.
*   **Simethicone:** Relieves gas by decreasing the surface tension of gas bubbles in the gastrointestinal tract, allowing them to coalesce and be expelled more easily.

## **Alternate Names**

Domperidone-Omeprazole-Simethicone; Omeprazole-Domperidone-Simethicone.  Several brand names exist depending on the region and manufacturer.


## **How It Works**

**Pharmacodynamics:**

*   **Omeprazole:** Suppresses gastric acid secretion, providing relief from acid-related symptoms and promoting ulcer healing.
*   **Domperidone:** Enhances gastric motility, accelerates gastric emptying, and reduces nausea and vomiting. Prolactin levels may be increased due to its dopamine antagonist action.
*   **Simethicone:** Decreases gas-related bloating, pressure, and abdominal discomfort.

**Pharmacokinetics:**

*   **Omeprazole:** Metabolized by the liver (CYP450 enzymes) and excreted mainly in the urine.
*   **Domperidone:** Metabolized by the liver (CYP3A4) and excreted in both urine and feces.
*   **Simethicone:** Not absorbed systemically; passes through the GI tract unchanged and is eliminated in the feces.

**Mode of Action:** See Mechanism of Action above.  Omeprazole inhibits the proton pump, domperidone is a peripheral dopamine antagonist, and simethicone reduces surface tension of gas bubbles.

**Receptor binding, enzyme inhibition, or neurotransmitter modulation:** 
* Omeprazole:  Inhibits H+/K+-ATPase.
* Domperidone:  Dopamine D2 receptor antagonist.


**Elimination pathways:**

*   **Omeprazole:** Primarily renal excretion.
*   **Domperidone:** Renal and hepatic excretion.
*   **Simethicone:** Fecal excretion.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

Omeprazole 20 mg + Domperidone 10 mg, taken orally twice daily, approximately 30-60 minutes before meals. Simethicone, when included, is typically 20-40 mg, administered after meals and at bedtime.

#### **Children:**

The safety and efficacy in children under 12 have not been definitively established. Simethicone pediatric dosing is generally weight-based (e.g., 20 mg for infants under 2 years, up to 40 mg for children over 2, after meals and at bedtime).  Omeprazole and domperidone dosing would require careful consideration of weight and age.

#### **Special Cases:**

*   **Elderly Patients:** Initiate with the lowest effective dose and monitor for side effects. Adjust according to renal function.
*   **Patients with Renal Impairment:** Use with caution. Modify dosage based on creatinine clearance.
*   **Patients with Hepatic Dysfunction:** Start with the lowest dose and monitor for adverse effects.
*   **Patients with Comorbid Conditions:** Evaluate potential drug interactions, particularly with medications metabolized by CYP450 enzymes.

### **Clinical Use Cases**

Dosing for specific clinical situations like intubation, surgical procedures, mechanical ventilation, ICU use, or emergencies is not standardized for this specific combination and would need to be determined based on individual patient needs.

### **Dosage Adjustments**

Adjustments are necessary based on renal/hepatic function, drug interactions, and other patient-specific factors.


## **Side Effects**

### **Common Side Effects**

Headache, diarrhea, abdominal pain, flatulence, dry mouth, drowsiness, dizziness.

### **Rare but Serious Side Effects**

Cardiac arrhythmias (especially with higher domperidone doses or prolonged use), extrapyramidal reactions (rare in adults), gynecomastia, galactorrhea, hypersensitivity reactions.

### **Long-Term Effects**

Potential for osteoporosis and increased risk of bone fractures with long-term PPI use, especially at higher doses.

### **Adverse Drug Reactions (ADR)**

Any signs of cardiac arrhythmias, extrapyramidal symptoms, or hypersensitivity reactions should prompt immediate intervention.

## **Contraindications**

Hypersensitivity to any of the components, gastrointestinal obstruction or bleeding, prolactinoma, severe hepatic impairment, concomitant use of drugs that prolong the QT interval.


## **Drug Interactions**

Omeprazole and domperidone can interact with numerous medications metabolized by the liver (CYP450, especially CYP3A4 and CYP2C19), including certain antibiotics, antifungals, antiretrovirals, anticoagulants, and antidepressants. Interactions with ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin, and amiodarone are particularly noteworthy. Concomitant use of drugs that prolong the QT interval should be avoided. Alcohol may exacerbate acidity. Antacids containing magnesium or aluminum can have additive or opposing effects on bowel movements when taken with this combination.



## **Pregnancy and Breastfeeding**

Use with caution during pregnancy only if clearly needed. While omeprazole and simethicone are generally considered low risk, domperidone has limited safety data and is present in breast milk.  Breastfeeding is generally not recommended while taking domperidone.


## **Drug Profile Summary**

*   **Mechanism of Action:** Omeprazole inhibits gastric acid secretion, domperidone increases gastric motility, and simethicone reduces gas.
*   **Side Effects:** Common: Headache, diarrhea, abdominal pain, flatulence, dry mouth. Serious: Cardiac arrhythmias, extrapyramidal reactions.
*   **Contraindications:** Hypersensitivity, GI bleeding/obstruction, prolactinoma.
*   **Drug Interactions:** CYP450 interactions, QT-prolonging drugs.
*   **Pregnancy & Breastfeeding:** Use with caution. Not recommended during breastfeeding.
*   **Dosage:** See above.
*   **Monitoring Parameters:**  Cardiac rhythm, electrolyte levels (with long-term PPI use), signs of extrapyramidal symptoms.


## **Popular Combinations**

While domperidone is sometimes combined with other PPIs or antacids, the triple combination with omeprazole and simethicone addresses acidity, motility, and gas simultaneously.


## **Precautions**

Screen patients for allergies, organ dysfunction, and concomitant medications. Caution is advised in the elderly, patients with renal/hepatic impairment, and those with cardiovascular disease. Alcohol should be avoided. Avoid operating machinery if drowsiness occurs. 


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Domperidone + Omeprazole + Simethicone?**

**A:**  Typical adult dosage is omeprazole 20 mg + domperidone 10 mg twice daily before meals, with simethicone 20-40 mg after meals and at bedtime.

### **Q2: Can this combination be used in children?**

**A:**  Safety and efficacy haven't been fully established in children under 12. Simethicone can be used based on weight, but omeprazole and domperidone dosing needs careful consideration in pediatrics.

### **Q3: What are the common side effects?**

**A:**  Headache, diarrhea, abdominal pain, flatulence, dry mouth, drowsiness, dizziness.

### **Q4: Are there any serious side effects?**

**A:** Yes, though rare.  Cardiac arrhythmias, extrapyramidal reactions, gynecomastia, and hypersensitivity reactions are possible.

### **Q5: What are the contraindications?**

**A:** Hypersensitivity, GI bleeding/obstruction, prolactinoma, severe hepatic impairment, and concomitant use of QT-prolonging drugs.

### **Q6:  What are the key drug interactions?**

**A:**  Numerous drug interactions exist, primarily through CYP450 enzymes.  Interactions with azoles, macrolides, and QT prolonging drugs are especially important.

### **Q7: Can this be used during pregnancy and breastfeeding?**

**A:**  Use cautiously during pregnancy only if the benefit clearly outweighs the risk. Breastfeeding is not generally recommended due to the presence of domperidone in breast milk. 

### **Q8: What should I monitor in patients taking this combination long-term?**

**A:** Electrolytes (magnesium, calcium), cardiac rhythm, and any signs of extrapyramidal symptoms, especially in elderly patients.



### **Q9: Should I advise any lifestyle modifications?**

**A:** Patients should avoid alcohol and fatty meals, which can exacerbate symptoms or reduce drug efficacy.  

### **Q10: Is there a risk of long-term PPI use?**

**A:** Yes, there's a potential increased risk of osteoporosis and bone fractures, especially with high doses and prolonged use.

